Legal Representation
Attorney
Beth M. Goldman
USPTO Deadlines
Application History
26 events| Date | Code | Type | Description | Documents |
|---|---|---|---|---|
| Jul 5, 2001 | ABN6 | S | ABANDONMENT - NO USE STATEMENT FILED | Loading... |
| Jan 17, 2001 | EX5G | S | SOU EXTENSION 5 GRANTED | Loading... |
| Nov 9, 2000 | EXT5 | S | SOU EXTENSION 5 FILED | Loading... |
| Jul 24, 2000 | EX4G | S | SOU EXTENSION 4 GRANTED | Loading... |
| May 26, 2000 | EXT4 | S | SOU EXTENSION 4 FILED | Loading... |
| Jan 2, 2000 | EX3G | S | SOU EXTENSION 3 GRANTED | Loading... |
| Nov 19, 1999 | EXT3 | S | SOU EXTENSION 3 FILED | Loading... |
| Mar 31, 1999 | EX2G | S | SOU EXTENSION 2 GRANTED | Loading... |
| Mar 8, 1999 | EXT2 | S | SOU EXTENSION 2 FILED | Loading... |
| Dec 17, 1998 | EX1G | S | SOU EXTENSION 1 GRANTED | Loading... |
| Nov 26, 1998 | EXT1 | S | SOU EXTENSION 1 FILED | Loading... |
| May 26, 1998 | NOAM | O | NOA MAILED - SOU REQUIRED FROM APPLICANT | Loading... |
| Nov 27, 1997 | IUCN | S | NOTICE OF ALLOWANCE CANCELLED | Loading... |
| Mar 17, 1998 | REIN | O | REINSTATED | Loading... |
| Jul 5, 2001 | ABN6 | S | ABANDONMENT - NO USE STATEMENT FILED | Loading... |
| May 27, 1997 | NOAM | O | NOA MAILED - SOU REQUIRED FROM APPLICANT | Loading... |
| Mar 4, 1997 | PUBO | A | PUBLISHED FOR OPPOSITION | Loading... |
| Jan 31, 1997 | NPUB | O | NOTICE OF PUBLICATION | Loading... |
| Dec 24, 1996 | CNSA | P | APPROVED FOR PUB - PRINCIPAL REGISTER | Loading... |
| Dec 4, 1996 | JURT | T | JURISDICTION RESTORED TO EXAMINING ATTORNEY | Loading... |
| Dec 4, 1996 | EXPI | T | EX PARTE APPEAL-INSTITUTED | Loading... |
| Feb 6, 1996 | CNFR | O | FINAL REFUSAL MAILED | Loading... |
| Feb 13, 1995 | CRFA | I | CORRESPONDENCE RECEIVED IN LAW OFFICE | Loading... |
| Sep 6, 1994 | CNRT | F | NON-FINAL ACTION MAILED | Loading... |
| Jul 26, 1994 | DOCK | D | ASSIGNED TO EXAMINER | Loading... |
| Jul 21, 1994 | DOCK | D | ASSIGNED TO EXAMINER | Loading... |
Detailed Classifications
Class 001
biochemicals; namely, monoclonal antibodies and fragments thereof for pharmaceutical and biological research and development
First Use Anywhere:
0
First Use in Commerce:
0
Class 005
cell lines for pharmaceutical research and development; and cell line products for pharmaceutical research and development, namely cell line pharmaceutical proteins and preparations for the treatment of cancer, autoimmune diseases, infectious diseases, inflammatory diseases and genetic diseases
First Use Anywhere:
0
First Use in Commerce:
0
Classification
International Classes
001
005
Disclaimers
The following terms have been disclaimed and are not claimed as part of the trademark:
General Disclaimer
"CELL"